Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TICS-DM: Ticagrelor vs Clopidogrel in T2DM and CAD
NCT02457130Phase 4Unknown
- Sponsor
- Sociedad Española de Cardiología
- Start
- Apr 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Sociedad Española de Cardiología. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02457130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457130.